Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways
Journal of Microbiology and Biotechnology · 2024
DOI: 10.4014/jmb.2406.06048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology and Biotechnology, 2024. Verfasst von Limin Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Puer People's Hospital, Puer 665000, P.R. China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease, Flavonols, Signal Transduction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Puer City Science and Technology Program, Kunming University of Science and Technology Joint Medical Special Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, Puer People's Hospital, Puer 665000, P.R. China.
- Department of Reproductive Genetics Center, Puer People's Hospital, Puer 665000, P.R. China.
- Department of Outpatient, Puer People's Hospital, Puer 665000, P.R. China.
Förderung
- Puer City Science and Technology Program
- Kunming University of Science and Technology Joint Medical Special Project
Zitieren
APA
Kang, L., Ma, X., Yu, F., Xu, L., & Lang, L. (2024). Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2406.06048
Vancouver
Kang L, Ma X, Yu F, Xu L, Lang L. Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways. Journal of Microbiology and Biotechnology. 2024. doi:10.4014/jmb.2406.06048
BibTeX
@article{Kang2024,
author = {Kang, Limin and Ma, Xiaolong and Yu, Fakun and Xu, Lei and Lang, Li},
title = {Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways},
journal = {Journal of Microbiology and Biotechnology},
year = {2024},
doi = {10.4014/jmb.2406.06048}
}
EUVIMED